Optina offers a non-invasive, readily accessible Retinal Deep PhenotypingTM platform to assess Brain Health. Optina’s pipeline includes a β-amyloid test for Alzheimer’s Disease, and additional early-stage biomarkers for cognitive health and other dementias.
